683
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Procalcitonin levels in community-acquired pneumonia – correlation with aetiology and severity

, , , , &
Pages 787-791 | Received 27 Mar 2014, Accepted 01 Jul 2014, Published online: 08 Sep 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Simon Athlin, Christer Lidman, Anders Lundqvist, Pontus Naucler, Anna C. Nilsson, Carl Spindler, Kristoffer Strålin & Jonas Hedlund. (2018) Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017. Infectious Diseases 50:4, pages 247-272.
Read now

Articles from other publishers (17)

Hans Kristian Floeystad, Jan Cato Holter, Einar Husebye, William Ward Siljan, Dag Berild, Are Martin Holm & Lars Heggelund. (2023) Nausea Predicts Bacteremia in Immunocompetent Patients with Pneumococcal Community-Acquired Pneumonia: Secondary Data Analysis from a Prospective Cohort. Journal of Clinical Medicine 12:12, pages 3924.
Crossref
Sedat Ozbay, Mustafa Ayan, Orhan Ozsoy, Canan Akman & Ozgur Karcioglu. (2023) Diagnostic and Prognostic Roles of Procalcitonin and Other Tools in Community-Acquired Pneumonia: A Narrative Review. Diagnostics 13:11, pages 1869.
Crossref
D. A. Strelkova, A. A. Irgiskin & S. A. Rachina. (2022) Differential diagnosis of community-acquired pneumonia and lung damage in respiratory viral infections, including COVID-19. PULMONOLOGIYA.
Crossref
S. N. Avdeev, A. V. Dekhnich, A. A. Zaytsev, R. S. Kozlov, S. A. Rachina, V. A. Rudnov, A. I. Sinopal’nikov, I. E. Tyurin, O. V. Fesenko & A. G. Chuchalin. (2022) Federal guidelines on diagnosis and treatment of community-acquired pneumonia. PULMONOLOGIYA 32:3, pages 295-355.
Crossref
S.N. Avdeev, V.B. Beloborodov, B.Z. Belotserkovskiy, A.I. Gritsan, A.V. Dekhnich, A.A. Zaytsev, M.Yu. Kirov, R.S. Kozlov, V.V. Kuzkov, D.N. Protsenko, S.A. Rachina, A.I. Sinopalnikov, S.V. Yakovlev & A.I. Yaroshetskiy. (2022) Severe community-acquired pneumonia in adults. Clinical recommendations from Russian Federation of Anaesthesiologists and Reanimatologists. Anesteziologiya i reanimatologiya:1, pages 6.
Crossref
С. Н. Авдеев, Борис Зиновьевич Белоцерковский, А. В. Дехнич, А. А. Зайцев, Р. С. Козлов, Д. Н. Проценко, С. А. Рачина, А. И. Синопальников, С. В. Яковлев & А. И. Ярошецкий. (2021) Современные подходы к диагностике, лечению и профилактике тяжелой внебольничной пневмонии у взрослых: обзор литературы. Annals of Critical Care:3, pages 27-46.
Crossref
Clarissa Valim, Yekin Ajauoi Olatunji, Yasir Shitu Isa, Rasheed Salaudeen, Sarwar Golam, Edward F Knol, Sheriffo Kanyi, Abdoulie Jammeh, Quique Bassat, Wilco de Jager, Alejandro A Diaz, Roger C Wiegand, Julio Ramirez, Marsha A Moses, Umberto D’Alessandro, Patricia L Hibberd & Grant A Mackenzie. (2021) Seeking diagnostic and prognostic biomarkers for childhood bacterial pneumonia in sub-Saharan Africa: study protocol for an observational study. BMJ Open 11:9, pages e046590.
Crossref
Takanori Akagi, Nobuhiko Nagata, Hiroyuki Miyazaki, Taishi Harada, Satoshi Takeda, Yuji Yoshida, Kenji Wada, Masaki Fujita & Kentaro Watanabe. (2019) Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital. BMC Geriatrics 19:1.
Crossref
Olivia L. Neeser, Tanja Vukajlovic, Laetitia Felder, Sebastian Haubitz, Angelika Hammerer-Lercher, Cornelia Ottiger, Beat Mueller, Philipp Schuetz & Christoph A. Fux. (2019) A high C-reactive protein/procalcitonin ratio predicts Mycoplasma pneumoniae infection . Clinical Chemistry and Laboratory Medicine (CCLM) 57:10, pages 1638-1646.
Crossref
Stefan Riedel. (2019) Predicting Bacterial Versus Viral Infection, or None of the Above. Clinics in Laboratory Medicine 39:3, pages 453-472.
Crossref
Takanori Akagi, Nobuhiko Nagata, Kentaro Wakamatsu, Taishi Harada, Hiroyuki Miyazaki, Satoshi Takeda, Shinichiro Ushijima, Takashi Aoyama, Yuji Yoshida, Hiroshi Yatsugi, Kenji Wada, Yusuke Ueda, Masaki Fujita & Kentaro Watanabe. (2019) Procalcitonin-Guided Antibiotic Discontinuation Might Shorten the Duration of Antibiotic Treatment Without Increasing Pneumonia Recurrence. The American Journal of the Medical Sciences 358:1, pages 33-44.
Crossref
Sheng Tao Yan, Li Chao Sun, Rui Lian, Yong Kang Tao, Hong Bo Zhang & Guoqiang Zhang. (2018) Diagnostic and predictive values of procalcitonin in bloodstream infections for nosocomial pneumonia. Journal of Critical Care 44, pages 424-429.
Crossref
Chris Stockmann, Krow Ampofo, Jarrett Killpack, Derek J Williams, Kathryn M Edwards, Carlos G Grijalva, Sandra R Arnold, Jonathan A McCullers, Evan J Anderson, Richard G Wunderink, Wesley H Self, Anna Bramley, Seema Jain, Andrew T Pavia & Anne J Blaschke. (2018) Procalcitonin Accurately Identifies Hospitalized Children With Low Risk of Bacterial Community-Acquired Pneumonia. Journal of the Pediatric Infectious Diseases Society 7:1, pages 46-53.
Crossref
Diego Viasus, Gaspar Del Rio-Pertuz, Antonella F. Simonetti, Carolina Garcia-Vidal, Jorge Acosta-Reyes, Argenis Garavito & Jordi Carratalà. (2016) Biomarkers for predicting short-term mortality in community-acquired pneumonia: A systematic review and meta-analysis. Journal of Infection 72:3, pages 273-282.
Crossref
Luisa Agnello, Chiara Bellia, Maria Di Gangi, Bruna Lo Sasso, Luca Calvaruso, Giulia Bivona, Concetta Scazzone, Piera Dones & Marcello Ciaccio. (2016) Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children. Clinical Biochemistry 49:1-2, pages 47-50.
Crossref
Hwan Soo Kim, Sulmui Won, Eu Kyoung Lee, Yoon Hong Chun, Jong-Seo Yoon, Hyun Hee Kim & Jin Tack Kim. (2016) Pentraxin 3 as a clinical marker in children with lower respiratory tract infection. Pediatric Pulmonology 51:1, pages 42-48.
Crossref
Po-Chuan Chen, Wen-I. Liao, Ying-Chuan Wang, Wei-Chou Chang, Chin-Wang Hsu, Ying-Hsin Chen & Shih-Hung Tsai. (2015) An Elevated Glycemic Gap is Associated With Adverse Outcomes in Diabetic Patients With Community-Acquired Pneumonia. Medicine 94:34, pages e1456.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.